A new research center makes a database of five million human pathology specimens and 22,000 living consented patients, all searchable by diagnoses, as well as cutting edge human analytic techniques available to anyone interested in carrying out translational skin disease research on human cells and tissues.
Taking the sting and stress out of dermatologic procedures requires low-tech distraction techniques and, often in the case of children, amusing apps.
Knowing the genetic basis of monogenic skin diseases may one day help dermatologists treat non-monogenic skin diseases as well.
CMS' meaningful use program for electronic health records (EHRs) has morphed into the Advancing Care Information (ACI) initiative, which loosens restrictions for earning EHR bonuses.
Promising new treatments recently approved or under development for atopic dermatitis include crisaborole, JAK inhibitors and dupilumab, an expert said.
Important recent publications from mainstream medical journals highlight the following: Automobile side windows do not block UV radiation well; An adjuvant herpes zoster vaccine works as well in patients over 70 years old as it did in the 50-plus age group; The American Academy of Ophthalmology recommends hydroxychloroquine and chloroquine dosing based on actual, not ideal, weight.
A recent pediatric allergy study spells out how to safely introduce peanuts to high-risk (and other) children. Another study suggests that melatonin may have immunomodulatory effects in AD.
The American Academy of Dermatology kicks off March 3. Follow here for updates on advancements in clinical dermatology.
Researchers have developed a 3D printer that applies skin cells onto burn wounds. Bio-printed cells enhanced wound healing by three to four weeks compared with untreated or matrix-treated wounds. Researchers are compiling animal data to submit an IND application for a clinical trial.
Why are drugs so expensive? It’s complicated. Who is profiting? Not just "Big Pharma". Is there a solution to this problem? Only if everyone is willing to pay their fair share.
Quality measurement, coverage trends are not new. Opportunity for specialty to develop its own valid data gathering methods. Dermatologists can seek guidance from specialties that have had success
The March Table of the Month discusses various dressing options and review times for certain wound types.
Much has been written and discussed over the last decade about accountability, particularly as it applies to the issue of liability for medical decision making in the care and treatment of healthcare plan enrollees and beneficiaries.
For answers, Dermatology Times and Cosmetic Surgery Times developed an online survey for readers. The activity presented images from 6 patients who were photographed on the day of their injection and 30 days after treatment with either Xeomin® (incobotulinumtoxinA, Merz Pharmaceuticals) or Botox® (onabotulinumtoxinA, Allergan).
In this complicated new era of health care, a prominent dermatologist says, there are some battles to fight and other changes to accept.
Hologic, a global healthcare and diagnostics company focused on woman’s health, announced Feb. 14, 2017, that it signed a definitive agreement to acquire all outstanding Cynosure shares, an equity value estimated at $1.65 billion.
Allergan has announced that it has agreed to acquire ZELTIQ Aesthetics for $2.475 billion, a deal expected to close in the second half of the year.
Researchers treated a small cohort with two anti-inflammatory drugs and saw a significant improvement in clinical manifestations of disease.Further data showed the approach safely maintained results.
Evidence supports combined treatments to target the many factors tied to hidradenitis suppurativa.
Dermatologists should consider the features of the nasal defect when weighing options for repair.Consider the desires of the patient when assessing options for both repair and treatments to mitigate post-surgical scar formation.The dermatologist must determine the choice of which procedure will likely achieve the best aesthetic outcome overall.
Combination therapies are under used; the role of diet, while controversial, may be beneficial; and, cosmeceuticals may remedy mild-to-moderate acne. Read more on acne treatment guidelines.
In our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
Residency isn't forever, and young dermatologists on the verge of starting their careers must make big decisions.
Be sure to follow these steps if you think you've been hacked.
Melanoma rates continue to rise, especially thin lesions which represents the largest group of fatalities. Gene expression profile tests can help diagnose or predict melanoma and are easy to use. But many dermatologists do not follow recommended treatment guidelines, which indicates a need to either educate practitioners or rethink the guidelines.
Since its introduction, isotretinoin has been reported to cause psychiatric problems or irritable bowel disease. Because different studies over the past 35 years do not support these claims dermatologists should not hesitate to prescribe this medication for their acne patients.
Three studies point to links between rosacea and numerous systemic comorbid diseases.
Because rosacea is an inflammatory disease there is scientific rationale for a possible association between it and other inflammatory diseases. A recent study demonstrates that rosacea patients have a greater percentage of gastrointestinal disorders than do controls and should be evaluated further if they present with GI symptoms. In such cases a systematic approach to the treatment of both conditions may be warranted.
Injectable fillers are considered to be safe in the hands of experienced dermatologists. But side effects are a possibility no matter how experienced the practitioner. A derm expert shares what colleagues need to know about filler complications and how to treat them.
It is unclear what constitutes “natural” soap, since all soap is really natural, however there is a trend toward the purchase of homemade soap.
